Neurite extension and In vitro myelination within three-dimensional modified fibrin matrices

Journal of Neurobiology

Volumn 63, Issue 1, 2005, Pages 1-14

  Pittier, Régis ^a   Sauthier, Fabrice ^a   Hubbell, Jeffrey A ^a,b   Hall, Heike ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

v 3 integrin; Fibrin matrix; In vitro myelination; Nerve regeneration; Sixth Ig like domain of cell adhesion molecule (L1Ig6)

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BIOMATERIAL; CELL ADHESION MOLECULE; CELL ADHESION MOLECULE L1; FIBRIN; LAMININ 1; MATRIX METALLOPROTEINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SERINE PROTEINASE; SIXTH IMMUNOGLOBULIN LIKE DOMAIN OF CELL ADHESION MOLECULE L1; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRAIN; CELL STRUCTURE; CELL SURFACE; DEGRADATION; DEVICE; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; FIBRIN CLOT; HUMAN; HUMAN CELL; IN VITRO STUDY; MYELINATION; NERVE INJURY; NERVE REGENERATION; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SPINAL GANGLION; THREE DIMENSIONAL FIBRIN MATRIX; TISSUE CULTURE; TISSUE REPAIR;

ANIMALS; ANTIBODIES; AZO COMPOUNDS; CHICK EMBRYO; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FACTOR XIII; FIBRIN; GANGLIA, SPINAL; GAP-43 PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; INTEGRINS; LAMININ; MODELS, BIOLOGICAL; MYELIN BASIC PROTEINS; MYELIN SHEATH; NEURAL CELL ADHESION MOLECULE L1; NEURITES; NEURONS; PC12 CELLS; PROTEASE INHIBITORS; RATS; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 14844293090     PISSN: 00223034     EISSN: None     Source Type: Journal    
DOI: 10.1002/neu.20116     Document Type: Article

References (46)

1. Adams RA, Passino M, Sachs BD, Nuriel T, Akassoglou K. 2004. Fibrin mechanisms and functions in nervous system pathology. Mol Interv 4:163-176.
2. Akassoglou K, Akpinar P, Murray S, Strickland S. 2003. Fibrin is a regulator of Schwann cell migration after sciatic nerve injury in mice. Neurosci Lett 338:185-188.
3. Akassoglou K, Kombrinck KW, Degen JL, Strickland S. 2000. Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury. J Cell Biol 149:1157-1166.
4. Akassoglou K, Strickland S. 2002. Nervous system pathology: the fibrin perspective. Biol Chem 383:37-45.
5. Akassoglou K, Yu WM. Akpinar P, Strickland S. 2002. Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation. Neuron 14:861-875.
6. Bartsch U. 2003. Neural cells and their role in the development and organization of myelin sheaths. Front Biosci 8:477-490.
7. Bini A, Itoh Y, Kudryk BJ, Nagase H. 1996. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (Stromolysin 1): Hydrolysis of the γ Gly 404-Ala 405 peptide bond. Biochemistry 35:13056-13063.
8. Bini A, Wu D, Schnuer J, Kudryk BJ. 1999. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrinogen fragments D-Dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments. Biochemistry 38:13928-13936.
9. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL. 1996. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87:709-719.
10. Bunge MB. 2001. Bridging areas of injury in the spinal cord. Neuroscientist 7:325-339.
11. Carenini S, Montag D, Schachner M, Martini R. 1998. MAG-deficient Schwann cells myelinate dorsal root ganglion neurons in culture. Glia 22:213-220.
12. Chen S, Mantei N, Dong L, Schachner M. 1999. Prevention of neuronal cell death by neural adhesion molecule L1 and CHL1. J Neurobiol 38:428-439.
13. Colognato H, Yurchenco PD. 2000. Form and Function: the laminin family of heterotrimers. Dev Dyn 218:213-234.
14. Deloulme JC, Mbele GO, Baudier J. 2002. S100 Proteins: From Purification to Functions. Calcium-binding Protein Protocols 1:185-198.
15. D'Urso D, Schmalenbach C, Zoidl G, Prior R, Mueller HW. 1997. Study of the effects of altered PMP22 expression during myelination in vitro. J Neurosci Res 48:31-42.
16. Garbay B, Haepe AM, Sargueil F, Cassagne C. 2000. Myelin synthesis in the peripheral nervous system. Prog Neurobiol 61:267-304.
17. Givogri MI, Bongarzone ER, Campagnoni AT. 2000. New insights on the biology of myelin basic protein gene: the neural-immune connection. J Neurosci Res 59:153-159.
18. Green LA, Tischler AS. 1976. Establishment of noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428.
19. Hall H, Baechi T, Hubbell JA. 2001. Molecular properties of fibrin-based hydrogels for angiogensis in vitro. Microvase Res 62:315-326.
20. Hall H, Djonov V, Ehrbar M, Hoechli M, Hubbell JA. 2004. Heterophilic interactions between cell adhesion molecule L1 and αvβ3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo. Angiogenesis, to appear.
21. Haspel J, Grumet M. 2003. The L1CAM extracellular region: a multi-domain protein with molecular and cooperative binding modes. Front Biosci 8:1210-1225.
22. Killer O, Lichte A, Oberpichler A, Kocourek A, Tschesche H. 2000. Matrix Metalloproteinases Collagenase-3, and Membrane Type 1-Matrix Metalloproteinase Impair Clotting by Degradation of Fibrinogen and Factor XII. J Biol Chem 275:33008-33013.
23. Hotary KB, Yana I, Sabeh F, Li XY, Holmbeck K, Birkedal-Hansen H, Allen ED, Hiraoka N, Weiss SJ. 2002. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J Exp Med 195:295-308.
24. Jessen KR, Mirsky R. 1999. Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci 22:402-410.
25. Kamigushi SG, Lemmon V. 1997. Neural cell adhesion molecule L1: signaling pathways and growth cone motility. J Neurosci Res 49:1-8.
26. Kenwrick S, Doherty P. 1998. Neural cell adhesion molecule Ll: relating disease to function. Bioassays 20:668-675.
27. Lagenaur C, Lemmon V. 1987. An L1-like molecule, the 8D9 antigen, is a potent substrate for neurite extension. Proc Natl Acad Sci USA 84:7753-7757.
28. Lemmon V, Farr K, Lagenaur C. 1989. L1-mediated axon outgrowth occurs via a homophilic binding mechanism. Neuron 2:1597-1603.
29. Martini R, Schachner M. 1986. Immunoelectron microscopic localization of neural cell adhesion molecules (L1, NCAM, and MAG) and their shared carbohydrate epitope and myelin basic protein in developing sciatic nerve. J Cell Biol 103:2439-2448.
30. Nehls V, Herrmann R. 1996. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. Microvasc Res 51:347-364.
31. Nicholson SM, Gomes D, de Nechaud B, Bruzzone R. 2001. Altered gene expression in Schwann Cells of Connexin32 Knockout animals. J Neurosci Res 66:23-36.
32. Previtali SC, Feltri ML, Archelos JJ, Quattrini A, Wrabetz L, Hartung HP. 2001. Role of integrins in the peripheral nervous system. Prog Neurobiol 64:35-49.
33. Previtali SC, Nodari A, Taveggia C, Pardini C, Dina G, Villa A, Wrabetz L, Quattrini A, Feltri ML. 2003. Expression of laminin Receptors in Schwann cell differentiation: Evidence for distinct roles. J Neurosci 23:5520-5530.
34. Rathjen FG, Schachner M. 1984. Immunocytological and biochemical characterization of a new neuronal cell adhesion surface component (L1 antigen) which is involved in cell adhesion. EMBO J 3:1-10.
35. Ryan EA, Mockros LF, Stern AM, Lorand L. 1999. Influence of a Natural and a Synthetic Inhibitor of Factor XIIIa on Fibrin Clot Rheology. Biophys J 77:2827-2836.
36. Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, Conn RD, Williamson RA, Sluka KA, Sherman DL, et al. 2003. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38:747-758.
37. Schense JC, Hubbell JA. 1999. Cross-linking exogenous bifunctional peptides into fibrin gels with Factor XIIIa. Bioconjugate Chem 10:75-81.
38. Scherer SS, Arroyo EJ. 2002. Recent progress on the molecular organization of myelinated axons. J Peripher Nerv Syst 7:1-12.
39. Seilheimer B, Persohn E, Schachner M. 1989. Antibodies to the L1 adhesion molecule inhibit Schwann cell ensheathment in vitro. J Cell Biol 109:3095-3103.
40. Takeda Y, Murakami Y, Asou H, Uyemura K. 2001. The roles of cell adhesion molecules on the formation of peripheral myelin. Keio J Med 50:240-248.
41. Urech L, Bittermann AG, Hubbell JA, Hall H. 2005. Physico-chemical properties and proteolytic degradability affect angiogenic process extension into native and modified fibrin matrices. Biomaterials, 26:1369-1379.
42. Vega JA, del Valle-Soto ME, Calzada B, Alvarez-Mendez JC. 1991. Immunohistochemical localization of S-100 protein subunits (alpha and beta) in dorsal root ganglia of the rat. Cell Mol Biol 37:173-181.
43. Walsh FS, Doherty P. 1997. Neural cell adhesion molecule of the immunoglobulin superfamily: role in axon growth and guidance. Annu Rev Cell Biol 13:425-456.
44. Yip PM, Siu CH. 2001. PC12 cells utilize the homophilic binding site of L1 for cell-cell adhesion but L1-αvβ3 interactions for neurite outgrowth. J Neurochem 76: 1552-1564.
45. Yip PM, Zhao X, Montgomery AMP, Siu CH. 1998. The Arg-Gly-Asp motif in the cell adhesion molecule L1 promotes neurite outgrowth via interaction with the αvβ3 integrin. Mol Biol Cell 9:277-290.
46. Yu X, Bellamkonda RV. 2001. Dorsal root ganglia neurite extension is inhibited by mechanical and chondroitin sulfate-rich matrices. J Neurosci Res 66:303-310.